Toxicological Interactions Between Alcohol and Benzodiazepines

REFERENCES

• , National Research Institute of Police Science: Annual Case Reports of Drug and Toxic Poisoning in Japan (1990–2000), No. 33‐42 (in Japanese).
   Google Scholar
• Sellers E.M., Busto U. Benzodiazepines and Ethanol: Assessment of the Effects and Consequences of Psychotropic Drug Interactions. J. Clin. Psychopharmacol. 1982; 2: 249–262
   PubMed Web of Science ®Google Scholar
• Tanaka E., Misawa S. Pharmacokinetic Interactions Between Acute Alcohol Ingestion and Single Doses of Benzodiazepines, and Tricyclic and Tetracyclic Antidepressants—An Update. J. Clin. Pharm. Ther. 1998; 23: 331–336
   PubMed Web of Science ®Google Scholar
• Sellers E.M., Holloway M.R. Drug Kinetics and Alcohol Ingestion. Clin. Pharmacokinet. 1978; 3: 440–452
   PubMed Web of Science ®Google Scholar
• Linnoila M., Mattila M.J., Kitchell B.S. Drug Interactions with Alcohol. Drugs 1979; 18: 299–311
   PubMed Web of Science ®Google Scholar
• Muhoberac B.B., Roberts R.K., Hoyumpa A.M., Scgenker S. Mechanism(s) of Ethanol–Drug Interaction. Alcohol Clin. Exp. Res. 1984; 8: 583–593
   PubMed Web of Science ®Google Scholar
• Weller R.A., Preskorn S.H. Psychotropic Drugs and Alcohol: Pharmacokinetic and Pharmacodynamic Interactions. Psychosomatics 1984; 25: 301–303, 305, 306, 309)
   PubMed Web of Science ®Google Scholar
• Hoyumpa A.M. Alcohol Interactions with Benzodiazepines and Cocaine. Adv. Alcohol Subst. Abuse 1984; 3: 21–31
   PubMedGoogle Scholar
• Lane E.A., Guthrie S., Linnoila M. Effects of Ethanol on Drug and Metabolite Pharmacokinetics. Clin. Pharmacokinet. 1985; 10: 228–247
   PubMed Web of Science ®Google Scholar
• Guthrie S.K., Lane E.A. Reinterpretation of the Pharmacokinetic Mechanism of Oral Benzodiazepine Ethanol Interaction. Alcohol Clin. Exp. Res. 1986; 10: 686–690
   PubMed Web of Science ®Google Scholar
• Mattila M.J. Alcohol and Drug Interactions. Ann. Med. 1990; 22: 363–369
   PubMed Web of Science ®Google Scholar
• Hollister L.E. Interactions Between Alcohol and Benzodiazepines. Recent Dev. Alcohol 1990; 8: 233–239
   PubMedGoogle Scholar
• Fraser A.G. Pharmacokinetic Interactions Between Alcohol and Other Drugs. Clin. Pharmacokinet. 1997; 33: 79–90
   PubMed Web of Science ®Google Scholar
• Ereshefsky L., Riesenman C., Lam Y.W.F. Antidepressant Drug Interactions and the Cytochrome P450 System. Clin. Pharmacokinet. 1995; 29(Suppl 1)10–19
   PubMedGoogle Scholar
• Taylor D., Malclmlader M. Cytochromes and Psychotropic Drug Interactions. Br. J. Psychiatry 1996; 168: 529–532
   PubMed Web of Science ®Google Scholar
• Shen W.W. The Metabolism of Psychoactive Drugs: A Review of Enzymatic Biotransformation and Inhibition. Biol. Psychiatry 1997; 41: 814–826
   PubMed Web of Science ®Google Scholar
• Beltilsson L., Dahl M.L., Tybring G. Pharmacogenetics of Antidepressants: Clinical Aspects. Acta Psychiatr. Scand. 1997; 96(Suppl 391)14–21
   PubMedGoogle Scholar
• Kronbach T., Mathys D., Umeno M., Gonzalez F.J., Meyer U.A. Oxidation of Midazolam and Triazolam by Human Liver Cytochrome P450IIIA4. Mol. Pharmacol. 1989; 36: 89–96
   PubMed Web of Science ®Google Scholar
• Andersson T., Miners J.O., Veronese M.E., Birkett D.J. Diazepam Metabolism by Human Liver Microsomes Is Mediated by Both S-Mephenytoin Hydroxylase and CYP3A Isoforms. Br. J. Clin. Pharmacol. 1994; 38: 131–137
   PubMed Web of Science ®Google Scholar
• von Moltke L.L., Greenblatt D.J., Cotreau-Bibbo M.M., Harmatz J.S., Shader R.I. Inhibitors of Alprazolam Metabolism In Vitro: Effect of Serotonin-Reuptake-Inhibitor Antidepressants, Ketoconazole and Quinidine. Br. J. Clin. Pharmacol. 1994; 38: 23–31
   PubMed Web of Science ®Google Scholar
• Yasumori T., Nagata K., Yang S.K., Chen L.S., Murayama N., Yamazoe Y., Kato R. Cytochrome P450 Mediated Metabolism of Diazepam in Human and Rat: Involvement of Human CYP2C in N-Demethylation in the Substrate Concentration-Dependent Manner. Pharmacogenetics 1993; 3: 291–301
   PubMedGoogle Scholar
• Ihara N., Kokufu T., Sugioka N., Ohta T., Nosaka K. Inhibitory Effect of Diltiazem on Diazepam Metabolism in the Mouse Hepatic Microsomes. Biol. Pharm. Bull. 1993; 16: 331–333
   PubMed Web of Science ®Google Scholar
• Seree E.J., Pisano P.J., Placidi M., Rahmani R., Barra Y.A. Identification of the Human and Animal Hepatic Cytochromes P450 Involved in Clonazepam Metabolism. Fundam. Clin. Pharmacol. 1993; 7: 69–75
   PubMed Web of Science ®Google Scholar
• Raunnio H., Pasanen M., Mäenpää J., Hokkola J., Pelkonen O. Expression of Extrahepatic Cytochrome P450 in Humans. Advances in Drug Metabolism in Man, G.M. Pacifici, G.N. Fracchia. European Commission, Office for Official Publications of the European Communities, Luxembourg 1995; 234–287
   Google Scholar
• Bertilsson L., Henthorn T.K., Sanz E., Tybring G., Sawe J., Villen T. Importance of Genetic Factors in the Regulation of Diazepam Metabolism: Relationship to S-Mephenytoin, But Not Debrisoquin, Hydroxylation Phenotype. Clin. Pharmacol. Ther. 1989; 45: 348–355
   PubMed Web of Science ®Google Scholar
• De Morais S.M., Wilkinson G.R., Blaisdell J., Meyer U.A., Nakamura K., Goldstein J.A. Identification of a New Genetic Defect Responsible for the Polymorphism of (S)-Mephenytoin Metabolism in Japanese. Mol. Pharmacol. 1994; 46: 594–598
   PubMed Web of Science ®Google Scholar
• Xiao Z.S., Goldstein J.A., Xie H.G., Blaisdell J., Wang W., Jiang C.H., Yan F.X., He N., Huang S.L., Xu Z.H., Zhou H.H. Differences in the Incidence of the CYP2C19 Polymorphism Affecting the S-Mephenytoin Phenotype in Chinese Han and Bai Populations and Identification of a New Rare CYP2C19 Mutant Allele. J. Pharmacol. Exp. Ther. 1997; 281: 604–609
   PubMed Web of Science ®Google Scholar
• Ferguson R.J., De Morais S.M., Benhamou S., Bouchardy C., Blaisdell J., Ibeanu G., Wilkinson G.R., Sarich T.C., Wright J.M., Dayer P., Goldstein J.A. A New Genetic Defect in Human CYP2C19: Mutation of the Initiation Codon Is Responsible for Poor Metabolism of S-Mephenytoin. J. Pharmacol. Exp. Ther. 1998; 284: 356–361
   PubMed Web of Science ®Google Scholar
• Mamiya K., Ieiri I., Shimamoto J., Yukawa E., Imai J., Ninomiya H., Yamada H., Otsubo K., Higuchi S., Tashiro N. The Effects of Genetic Polymorphisms of CYP2C9 and CYP2C19 on Phenytoin Metabolism in Japanese Adult Patients with Epilepsy: Studies in Stereoselective Hydroxylation and Population Pharmacokinetics. Epilepsia 1998; 39(12)1317–1323
   PubMed Web of Science ®Google Scholar
• Hoyumpa A.M., Patwardhan R., Maples M., Desmond P.V., Johnson R.F., Sinclair A.P., Schenker S. Effect of Short-Term Ethanol Administration on Lorazepam Clearance. Hepatology 1981; 1: 47–53
   PubMed Web of Science ®Google Scholar
• Griffin R.J., Burka L.T., Demby K.B. Oxidative Biotransformation of Oxazepam to Reactive and Nonreactive Products in Rat, Mouse and Human Microsomes. Hum. Exp. Toxicol. 1995; 14: 779–786
   PubMed Web of Science ®Google Scholar
• Lieber C.S. Mechanisms of Ethanol–Drug–Nutrition Interactions. J. Toxicol. Clin. Toxicol. 1994; 32: 631–681
   PubMed Web of Science ®Google Scholar
• Lieber C.S. Susceptibility to Alcohol-Related Liver Injury. Alcohol Suppl. 1994; 2: 315–326
   PubMedGoogle Scholar
• Kitson K.E. Ethanol and Acetaldehyde Metabolism: Past, Present, and Future. Alcohol Clin. Exp. Res. 1996; 20(Suppl 8)82A–92A
   Google Scholar
• Asai H., Imaoka S. Microsomal Ethanol Oxidizing System Activity by Human Hepatic Cytochrome P450's. J. Pharmacol. Exp. Ther. 1996; 277: 1004–1009
   PubMed Web of Science ®Google Scholar
• Song B.J. Ethanol-Inducible Cytochrome P450 (CYP2E1): Biochemistry, Molecular Biology and Clinical Relevance: 1996 Update. Alcohol Clin. Exp. Res. 1996; 20(Suppl 8)138A–146A
   Google Scholar
• Lieber C.S. Ethanol Metabolism, Cirrhosis and Alcoholism. Clin. Chim. Acta 1997; 257: 59–84
   PubMed Web of Science ®Google Scholar
• Sellers E.M., Giles H.G., Greenblatt D.J., Naranjo C.A. Differential Effects on Benzodiazepine Disposition by Disulfiram and Ethanol. Arzneimttelforschung 1980; 30: 882–886
   PubMed Web of Science ®Google Scholar
• Linnoila M., Stapleton J.M., Lister R., Moss H., Lane E., Granger A., Eckardt M.J. Effects of Single Doses of Alprazolam and Diazepam, Alone and in Combination with Ethanol, on Psychomotor and Cognitive Performance and on Autonomic Nervous System Reactivity in Healthy Volunteers. Eur. J. Clin. Pharmacol. 1990; 39: 21–28
   PubMed Web of Science ®Google Scholar
• Scavone J.M., Greenblatt D.J., Harmatz J.S., Shader R.I. Kinetic and Dynamic Interaction of Brotizolam and Ethanol. Br. J. Clin. Pharmacol. 1986; 21: 197–204
   PubMed Web of Science ®Google Scholar
• Divoll M., Greenblatt D.J. Alcohol Does Not Enhance Diazepam Absorption. Pharmacology 1981; 22: 263–268
   PubMed Web of Science ®Google Scholar
• Linnoila M., Stapleton J.M., Lister R., Moss H., Lane E., Granger A., Eckardt M.J. Effects of Adinazolam and Diazepam, Alone and in Combination with Ethanol, on Psychomotor and Cognitive Performance and on Autonomic Nervous System Reactivity in Healthy Volunteers. Eur. J. Clin. Pharmacol. 1990; 38: 371–377
   PubMed Web of Science ®Google Scholar
• Steveninck A.L.V., Gieschke R., Schoemaker R.C., Roncari G., Tuk B., Pieters M.S.M., Breimer D.D., Cohen A.F. Pharmacokinetic and Pharmacodynamic Interactions of Bretazenil and Diazepam with Alcohol. Br. J. Clin. Pharmacol. 1996; 41: 565–573
   PubMed Web of Science ®Google Scholar
• Ochs H.R., Greenblatt D.J., Arandt R.M., Hübbel W., Shader R.I. Pharmacokinetic Noninteraction of Triazolam and Ethanol. J. Psychopharmacol. 1984; 4: 106–107
   Web of Science ®Google Scholar
• Dorian P., Sellers E.M., Kaplan H.L., Hamilton C., Greenblatt D.J., Adernethy D. Triazolam and Ethanol Interaction: Kinetic and Dynamic Consequences. Clin. Pharmacol. Ther. 1985; 37: 558–562
   PubMed Web of Science ®Google Scholar
• Sellman R., Kanto J., Raijola E., Pekkarinen A. Human and Animal Study on Elimination From Plasma and Metabolism of Diazepam After Chronic Alcohol Intake. Acta Pharmacol. Toxicol. (Copenh.) 1975; 36: 33–38
   PubMedGoogle Scholar
• Sellman R., Pekkarinen A., Kangas L., Raijola E. Reduced Concentrations of Plasma Diazepam in Chronic Alcoholic Patients Following an Oral Administration of Diazepam. Acta Pharmacol. Toxicol. (Copenh.) 1975; 36: 25–32
   PubMedGoogle Scholar
• Pond S.M., Phillips M., Benowitz N.L., Galinsky R.E., Tong T.G., Becker C.E. Diazepam Kinetics in Acute Alcohol Withdrawal. Clin. Pharmacol. Ther. 1979; 25: 832–836
   PubMed Web of Science ®Google Scholar
• Sunter J.P., Bal T.S., Cowan W.K. Three Cases of Fatal Triazolam Poisoning. Br. Med. J. 1988; 297: 719
   PubMed Web of Science ®Google Scholar
• Bal T.S., Johnson B., Kilner E.A., Sunter J.P., Cowan W.K. Three Deaths Involving Triazolam—Analytical Aspects. J. Forensic Sci. Soc. 1989; 29: 119–123
   PubMedGoogle Scholar
• Wodak A., Pedersen C. A Death from Combined Alcohol and Benzodiazepine Poisoning in a Non-medical Detoxification Unit. Med. J. Aust. 1992; 156: 814
   PubMed Web of Science ®Google Scholar
• Joynt B.P. Triazolam Blood Concentrations in Forensic Cases in Canada. J. Anal. Toxicol. 1993; 17: 171–177
   PubMed Web of Science ®Google Scholar
• Steentoft A., Worm K. Cases of Fatal Triazolam Poisoning. J. Forensic Sci. Soc. 1993; 33: 45–48
   PubMedGoogle Scholar
• Drummer O.H., Syrjanen M.L., Cordner S.M. Deaths Involving the Benzodiazepine Flunitrazepam. Am. J. Forensic Med. Pathol. 1993; 14: 238–243
   PubMed Web of Science ®Google Scholar
• Uemura K., Komura S. Death Caused by Triazolam and Ethanol Intoxication. Am. J. Forensic Med. Pathol. 1995; 16: 66–68
   PubMed Web of Science ®Google Scholar
• Drummer O.H., Ranson D.L. Sudden Death and Benzodiazepines. Am. J. Forensic Med. Pathol. 1996; 17: 336–342
   PubMed Web of Science ®Google Scholar
• Michaud K., Augsburger M., Romain N., Giroud C., Mangin P. Fatal Overdose of Tramadol and Alprazolam. Forensic Sci. Int. 1999; 105: 185–189
   PubMed Web of Science ®Google Scholar
• O'Dowd J.J., Spragg P.P., Routledge P.A. Fatal Triazolam Poisoning. Br. Med. J. 1988; 297: 1048
   PubMed Web of Science ®Google Scholar